IFNA1 and Sjogren syndrome: Several studies have shown that overexpressed transcripts of the type I IFN pathway are also identified in patients with myositis, RA, Sjögren’s syndrome and scleroderma [42-44], so an IFN signature or chemokine is not sufficiently specific.